Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) is a publicly traded Healthcare sector company. As of May 21, 2026, EPRX trades at $6.66 with a market cap of $437.04M and a P/E ratio of 0.00. EPRX moved +1.27% today. Year to date, EPRX is -17.06%; over the trailing twelve months it is +63.34%. Its 52-week range spans $2.20 to $9.32. Analyst consensus is strong buy with an average price target of $14.80. Rallies surfaces EPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. EPRX moved +1.27% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $6.66 |
| Market Cap | $437.04M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.32 |
| 52-Week Low | $2.20 |
| Volume | 205.79K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover EPRX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.80.